Samantha has a distinguished track record as a life science sector investor, asset manager, entrepreneur and scientist. She is founder of Surrey Capital Partners, a life science impact innovation fund. Samantha is passionate on advancing the fields of science and engineering that will define the medicine of tomorrow. Surrey Capital Partners is a Fund focused in the life sciences industry with an exclusive access to a pipeline of Biotech and Healthcare companies, founding early to mid-stage technologies, and building life-changing devices. Over a decade, Samantha developed a wide network from her previous experiences of investing and managing over GBP 4 billion in transactions. As an Entrepreneur, Samantha has successfully founded and sold her companies. Samantha currently sits on the board of Advisors for University Of Pennsylvania School for Engineering, Cornell University Entrepreneurship, Endeavor Healthcare, DSMC, an incredible Ultrasound Imaging Device, AZ Therapies, a late stage stroke company, and Google Accelerator with a special focus on A.I. for Healthcare.
Samantha is Co-Founder and Managing Partner, Decision Medical Ventures, a New York and California-based life sciences investment firm. She currently sits on the board of Decision Sciences Medical Company, an affiliate of Decision Sciences focused on bringing to market an advanced medical ultrasound technology for the early, non- invasive detection of cancer and other serious medical conditions.Samantha’s experience includes working for a large pharmaceutical company in WorldWide Business Development, R&D, and Mergers and Acquisitions. She has managed and closed investments in the pharmaceutical, biotechnology, medical device and diagnostics areas. Samantha has 14 years of experience working in the life sciences/pharmaceutical industry in the areas of Private Equity Venture Capital, as well as business development for a major pharmaceutical company. She was responsible for managing a portfolio of investments and negotiating global deals in licensing, collaborations, and acquisitions with other pharmaceutical and biotech companies, fund of fund investments, and financial valuations.
Samantha previously worked at a venture capital private equity fund in London, focusing on life sciences in areas of biotechnology, medical devices, therapeutics, and nanotechnology. She also held positions at the Cabinet Office in the Ministry of Science and Technology working on the Global Innovation Forum.
Samantha graduated summa cum laude with an M.S. Eng. and a M.B. in biomedical engineering and biotechnology, respectively, from University of Pennsylvania, with a joint published thesis from the Library of Congress in robotic surgery with the Engineering School at Oxford University. Samantha holds an undergraduate degree in Engineering and Applied Mathematics from Cornell University. She has recently been asked to join the University of Pennsylvania School for Engineering and Medicine as a faculty advisory board member and the Cornell Entrepreneurship Advisory Council.
She has a published paper that was presented at the Engineering and Medicine Society Conference in France with the Jet Propulsion Laboratory and NASA, as well a published thesis on Artificial Muscles and the Applications to Robotic Surgery. Samantha holds numerous publications as well as a patent in 3-D protein modeling sold to Microsoft for genomics. She has an Executive Finance Degree from Wharton and completed the Private Equity Venture Capital Program at Harvard Business School. She graduated from the Owner’s President Management Program (OPM 53) at
Harvard Business School in 2019. She was nominated for the “Rising Star” awardin Science, Women, and Engineering in 2010.